• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降低卒中后风险行为:使用理论领域框架对初级研究数据进行审查的概述。

Reducing risk behaviours after stroke: An overview of reviews interrogating primary study data using the Theoretical Domains Framework.

机构信息

School of Public Health, Physiotherapy and Sports Science, Health Science Centre, University College Dublin, Dublin, Ireland.

iPASTAR (Improving Pathways for Acute Stroke and Rehabilitation) Collaborative Doctoral Award, Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.

出版信息

PLoS One. 2024 Apr 26;19(4):e0302364. doi: 10.1371/journal.pone.0302364. eCollection 2024.

DOI:10.1371/journal.pone.0302364
PMID:38669261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11051587/
Abstract

BACKGROUND

Lifestyle changes, in addition to preventive medications, optimise stroke secondary prevention. Evidence from systematic reviews support behaviour-change interventions post-stroke to address lifestyle-related risk. However, understanding of the theory-driven mediators that affect behaviour-change post-stroke is lacking.

METHODS

Electronic databases MEDLINE, Embase, Epistemonikos and Cochrane Library of Systematic Reviews were searched to March 2023 for systematic reviews addressing behaviour-change after stroke. Primary studies from identified systematic reviews were interrogated for evidence supporting theoretically-grounded interventions. Data were synthesized in new meta-analyses examining behaviour-change domains of the Theoretical Domains Framework (TDF) and secondary prevention outcomes.

RESULTS

From 71 identified SRs, 246 primary studies were screened. Only 19 trials (N = 2530 participants) were identified that employed theoretically-grounded interventions and measured associated mediators for behaviour-change. Identified mediators mapped to 5 of 14 possible TDF domains. Trial follow-up ranged between 1-12 months and no studies addressed primary outcomes of recurrent stroke or cardiovascular mortality and/or morbidity. Lifestyle interventions targeting mediators mapped to the TDF Knowledge domain may improve the likelihood of medication adherence (OR 6.08 [2.79, 13.26], I2 = 0%); physical activity participation (OR 2.97 [1.73, 5.12], I2 = 0%) and smoking cessation (OR 10.37 [3.22, 33.39], I2 = 20%) post-stroke, supported by low certainty evidence; Lifestyle interventions targeting mediators mapping to both TDF domains of Knowledge and Beliefs about Consequences may improve medication adherence post-stroke (SMD 0.36 [0.07, 0.64], I2 = 13%, very low certainty evidence); Lifestyle interventions targeting mediators mapped to Beliefs about Capabilities and Emotions domains may modulate low mood post-stroke (SMD -0.70 [-1.28, -0.12], I2 = 81%, low certainty evidence).

CONCLUSION

Limited theory-based research and use of behaviour-change mediators exists within stroke secondary prevention trials. Knowledge, Beliefs about Consequences, and Emotions are the domains which positively influence risk-reducing behaviours post-stroke. Behaviour-change interventions should include these evidence-based constructs known to be effective. Future trials should address cardiovascular outcomes and ensure adequate follow-up time.

摘要

背景

除了预防药物外,生活方式的改变也能优化中风二级预防。系统评价的证据支持中风后进行以行为改变为基础的干预措施,以解决与生活方式相关的风险。然而,对于影响中风后行为改变的理论驱动因素知之甚少。

方法

检索了 MEDLINE、Embase、Epistemonikos 和 Cochrane 系统评价数据库,以获取 2023 年 3 月前针对中风后行为改变的系统评价。从确定的系统评价中对初级研究进行了查询,以获取支持基于理论的干预措施的证据。使用理论领域框架(TDF)的行为改变领域和二级预防结果进行了新的荟萃分析来综合数据。

结果

从 71 项 SR 中,筛选出 246 项初级研究。仅确定了 19 项试验(N = 2530 名参与者)采用了基于理论的干预措施,并测量了与行为改变相关的中介因素。确定的中介因素映射到 TDF 的 14 个可能领域中的 5 个。试验随访时间在 1-12 个月之间,没有研究涉及中风复发或心血管死亡率和/或发病率等主要结局。针对 TDF 知识领域中介因素的生活方式干预措施可能会提高药物依从性的可能性(OR 6.08 [2.79, 13.26],I2 = 0%)、体力活动参与度(OR 2.97 [1.73, 5.12],I2 = 0%)和中风后戒烟(OR 10.37 [3.22, 33.39],I2 = 20%),这得到了低确定性证据的支持;针对 TDF 知识和后果信念领域中介因素的生活方式干预措施可能会提高中风后药物依从性(SMD 0.36 [0.07, 0.64],I2 = 13%,非常低确定性证据);针对 TDF 信念能力和情绪领域中介因素的生活方式干预措施可能会调节中风后的情绪低落(SMD -0.70 [-1.28, -0.12],I2 = 81%,低确定性证据)。

结论

中风二级预防试验中基于理论的研究和行为改变中介因素的使用有限。知识、后果信念和情绪是积极影响中风后风险降低行为的领域。行为改变干预措施应包括这些已知有效的基于证据的结构。未来的试验应关注心血管结局并确保足够的随访时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d515/11051587/a2599440d8b9/pone.0302364.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d515/11051587/e32589faa260/pone.0302364.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d515/11051587/85a63600dab7/pone.0302364.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d515/11051587/55d5354126ba/pone.0302364.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d515/11051587/777fc7a781e9/pone.0302364.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d515/11051587/a2599440d8b9/pone.0302364.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d515/11051587/e32589faa260/pone.0302364.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d515/11051587/85a63600dab7/pone.0302364.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d515/11051587/55d5354126ba/pone.0302364.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d515/11051587/777fc7a781e9/pone.0302364.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d515/11051587/a2599440d8b9/pone.0302364.g005.jpg

相似文献

1
Reducing risk behaviours after stroke: An overview of reviews interrogating primary study data using the Theoretical Domains Framework.降低卒中后风险行为:使用理论领域框架对初级研究数据进行审查的概述。
PLoS One. 2024 Apr 26;19(4):e0302364. doi: 10.1371/journal.pone.0302364. eCollection 2024.
2
Interventions for Behaviour Change and Self-Management of Risk in Stroke Secondary Prevention: An Overview of Reviews.中风二级预防中行为改变与风险自我管理的干预措施:综述概述
Cerebrovasc Dis. 2024;53(1):1-13. doi: 10.1159/000531138. Epub 2023 May 25.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Interventions for behaviour change and self-management in stroke secondary prevention: protocol for an overview of reviews.干预措施对行为改变和自我管理在中风二级预防:协议的概述审查。
Syst Rev. 2018 Dec 13;7(1):231. doi: 10.1186/s13643-018-0888-1.
5
Effectiveness of behavior change and self-management theoretically-informed telehealth interventions for stroke secondary prevention: An overview of systematic reviews.基于理论的行为改变和自我管理远程医疗干预对卒中二级预防的有效性:系统评价概述
J Telemed Telecare. 2024 Apr 16:1357633X241238779. doi: 10.1177/1357633X241238779.
6
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.行为修正干预对初级保健中无法用医学解释的症状:系统评价和经济评估。
Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460.
7
Secondary prevention lifestyle interventions initiated within 90 days after TIA or 'minor' stroke: a systematic review and meta-analysis of rehabilitation programmes.短暂性脑缺血发作(TIA)或“轻度”中风后90天内启动的二级预防生活方式干预:康复计划的系统评价和荟萃分析
Br J Gen Pract. 2017 Jan;67(654):e57-e66. doi: 10.3399/bjgp16X688369. Epub 2016 Dec 5.
8
Interventions for reducing sedentary behaviour in people with stroke.干预措施减少脑卒中患者的久坐行为。
Cochrane Database Syst Rev. 2021 Jun 29;6(6):CD012996. doi: 10.1002/14651858.CD012996.pub2.
9
Community pharmacy interventions for health promotion: effects on professional practice and health outcomes.社区药房促进健康干预措施:对专业实践和健康结果的影响。
Cochrane Database Syst Rev. 2019 Dec 6;12(12):CD011207. doi: 10.1002/14651858.CD011207.pub2.
10
Internet-based interventions for the secondary prevention of coronary heart disease.基于互联网的冠心病二级预防干预措施。
Cochrane Database Syst Rev. 2015 Dec 22;2015(12):CD009386. doi: 10.1002/14651858.CD009386.pub2.

引用本文的文献

1
Identifying mediators of healthy lifestyle adoption after stroke: a focus group study using a Theoretical Domains Framework guided analysis.识别中风后采用健康生活方式的影响因素:一项使用理论领域框架指导分析的焦点小组研究。
BMC Neurol. 2025 Apr 2;25(1):135. doi: 10.1186/s12883-025-04144-1.

本文引用的文献

1
What follow-up interventions, programmes and pathways exist for minor stroke survivors after discharge from the acute setting? A scoping review.出院后,轻度中风幸存者有哪些后续干预、方案和途径?一项范围综述。
BMJ Open. 2023 Jun 13;13(6):e070323. doi: 10.1136/bmjopen-2022-070323.
2
The use of mindfulness-based interventions in stroke rehabilitation: A scoping review.基于正念的干预措施在中风康复中的应用:范围综述。
Rehabil Psychol. 2023 Aug;68(3):221-234. doi: 10.1037/rep0000505. Epub 2023 Jun 1.
3
Interventions for Behaviour Change and Self-Management of Risk in Stroke Secondary Prevention: An Overview of Reviews.
中风二级预防中行为改变与风险自我管理的干预措施:综述概述
Cerebrovasc Dis. 2024;53(1):1-13. doi: 10.1159/000531138. Epub 2023 May 25.
4
Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.医疗干预措施系统评价概述报告规范:PRIOR 声明的制定。
BMJ. 2022 Aug 9;378:e070849. doi: 10.1136/bmj-2022-070849.
5
Social Determinants of Stroke Hospitalization and Mortality in United States' Counties.美国各县中风住院和死亡率的社会决定因素
J Clin Med. 2022 Jul 15;11(14):4101. doi: 10.3390/jcm11144101.
6
A Scoping Review of Non-Pharmacological, Non-Surgical Secondary Prevention Strategies in Ischaemic Stroke and TIA in National Stroke Guidelines and Clinical Audit Documents.国家卒中指南和临床审计文件中缺血性卒中和短暂性脑缺血发作非药物、非手术二级预防策略的范围综述
Healthcare (Basel). 2022 Mar 4;10(3):481. doi: 10.3390/healthcare10030481.
7
Information provision for stroke survivors and their carers.为脑卒中幸存者及其照护者提供信息。
Cochrane Database Syst Rev. 2021 Nov 23;11(11):CD001919. doi: 10.1002/14651858.CD001919.pub4.
8
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance.制定和评估复杂干预措施的新框架:对医学研究理事会指南的更新。
BMJ. 2021 Sep 30;374:n2061. doi: 10.1136/bmj.n2061.
9
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association.《2021年卒中与短暂性脑缺血发作患者卒中预防指南:美国心脏协会/美国卒中协会指南》
Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24.
10
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.